Literature DB >> 7263639

Isolation and preliminary characterization of proteoglycans dissociatively extracted from human aorta.

B G Salisbury, W D Wagner.   

Abstract

Aortic proteoglycans (PG) were isolated from human aorta intima-media preparations with 4 M guanidine hydrochloride in the presence of protease inhibitors. The extracted PG mixture comprised 67% of the total aortic PG and was composed of 65% chondroitin sulfate, 22% dermatan sulfate, 8% heparan sulfate, and 4% hyaluronate. Attempts at isolation and purification of PG monomers using isopycnic CsCl gradient centrifugation under associative and dissociative conditions resulted in appreciable loss of PG through associations with co-extracted aortic proteins. The addition of a gel chromatographic step on Sepharose CL-4B under dissociative conditions resulted in separation of PG from the majority of co-extracted proteins. In addition, the procedure resulted in a separation of the PG into a population (PG-I) eluting near the column V0 and one (PG-II) included with a Kav of 0.38. Hyaluronic acid co-eluted with PG-I. The major glycosaminoglycan in PG-I was chondroitin sulfate, (85 to 95%). No dermatan sulfate was detected in PG-I, but this glycosaminoglycan was the predominant glycosaminoglycan in PG-II (50 to 70%). Heparan sulfate was present in small amounts in both PG-I and PG-II. Data presented support the proposal of at least three species of PG monomers in the aortic wall. Chromatographic studies under dissociative and associative conditions indicated that PG comprising PG-I but not PG-II were capable of associations with hyaluronic acid.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Pivotal role for decorin in angiogenesis.

Authors:  Hannu Järveläinen; Annele Sainio; Thomas N Wight
Journal:  Matrix Biol       Date:  2015-02-07       Impact factor: 11.583

2.  Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells.

Authors:  I J Edwards; W D Wagner; R T Owens
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

3.  Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA.

Authors:  T Krusius; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 4.  Proteoglycans in health and disease: structures and functions.

Authors:  A R Poole
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

5.  Investigation of relationships between collagens, elastin and proteoglycans in bovine thoracic aorta by immunofluorescence techniques.

Authors:  J S Bartholomew; J C Anderson
Journal:  Histochem J       Date:  1983-12

6.  The core proteins of large and small interstitial proteoglycans from various connective tissues form distinct subgroups.

Authors:  D Heinegård; A Björne-Persson; L Cöster; A Franzén; S Gardell; A Malmström; M Paulsson; R Sandfalk; K Vogel
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

7.  Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages.

Authors:  B G Salisbury; D J Falcone; C R Minick
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

8.  Localization of proteoheparan sulfate in rat aorta.

Authors:  A W Clowes; M M Clowes; A M Gown; T N Wight
Journal:  Histochemistry       Date:  1984

9.  Physical properties of chondroitin sulphate/dermatan sulphate proteoglycans from bovine aorta.

Authors:  R Kapoor; C F Phelps; T N Wight
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

10.  Hyaluronic acid accumulation and endothelial cell detachment in intimal thickening of the vessel wall. The normal and genetically defective ductus arteriosus.

Authors:  E G De Reeder; N Girard; R E Poelmann; J C Van Munsteren; D F Patterson; A C Gittenberger-De Groot
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.